Jonathan Kim, DPM
Podiatrist · San Gabriel, CANPI 1104220102
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (51.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 79.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $4,172 and has fallen 99.6% since, to $18 in 2022.
Across 53 payments — averaging $105.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Treace Medical Concepts, Inc.$434
- Smith+Nephew$434
- Zimmer Biomet$93
- Organogenesis Inc.$42
- Johnson & Johnson$30
- plus $123 from 6 others
What the payments were for
- Travel & lodging$77914%
- Food & beverage$1,96035%
- Education$2,86751%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 23 | $4,450 |
| Treace Medical Concepts, Inc. | 2 | $434 |
| Smith+Nephew | 14 | $434 |
| Zimmer Biomet | 4 | $93 |
| Organogenesis Inc. | 2 | $42 |
| Johnson & Johnson | 2 | $30 |
| Orthofix Medical, Inc. | 1 | $28 |
| Stryker | 1 | $24 |
| Osiris Therapeutics Inc. | 1 | $22 |
| Nevro Corp. | 1 | $18 |
| Merck | 1 | $16 |
| Tactile Systems Technology Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$337
- Stravix$122
- Grafix$122
- GrafixPL$122
How this compares
$5,606 in reported general payments places this provider in the 85th percentile of 721 podiatrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 92 | $1,562 |
| Ketoconazole | 16 | $339 |
| Cephalexin | 38 | $304 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in San Gabriel
- Shannon RushPleasanton$1.9M
- Babak BaravarianSanta Monica$1.1M
- Robert KleimanCalexico$913K
- Bruce LawrenceOceanside$810K
- David ArmstrongLos Angeles$695K
- Philip WrotslavskyPoway$269K
- Travis WestermeyerEncinitas$158K
- Adrienne EstesPomona$129K
- Ronald LiebermanEncinitas$109K
- Matthew DoyleMountain View$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.